Search
for

    Research 1

    1. LB1681 Risk of merkel cell carcinoma progression after treatment discontinuation in patients with an objective response to anti-PD-(L)1 immunotherapy 2023

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →